Tumor-Localizing Lymphocytotoxic Antibodies

  • Maya Ran
  • Margalit Yaakubowicz
  • Ora Amitai
  • Isaac P. Witz
Part of the Contemporary Topics in Immunobiology book series (CTI, volume 10)


Humoral tumor immunity as expressed within the tumor tissue has been studied in several laboratories, including ours (Witz, 1977). There is little doubt that immunoglobulin molecules are associated with cells lodging in the tumors of humans and of animals. A preferential association between Ig and tumor tissues was indicated in some cases (Ran and Witz, 1970).


Tumor Bearer L5178Y Cell Cytotoxicity Index Antilymphocyte Antibody Antitumor Antibody 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. Allison, A. C., Denman, A. M., and Barnes, R. D., 1971, Cooperating and controlling functions of thymus-derived lymphocytes in relation to auto immunity, Lancet 2: 135.PubMedCrossRefGoogle Scholar
  2. Andersen, P., and Andersen, H. K., 1975, Smooth-muscle antibodies and other tissue antibodies in cytomegalovirus infection, Clin. Exp. Immunol. 22: 22.PubMedGoogle Scholar
  3. Braslawsky, G. R., Ran, M., and Witz, I. P., 1976a, Tumor-bound immunoglobulins: The relationship between the in vivo coating of tumor cells by potentially cytotoxic antitumor antibodies, and the expression of immune complex receptors, Int. J. Cancer 18: 116.PubMedCrossRefGoogle Scholar
  4. Braslawsky, G. R., Serban, D., and Witz, I. P., 1976b, Receptors for immune complexes on cells within a polyoma-virus-induced murine sarcoma, Eur. J. Immunol. 6: 579.PubMedCrossRefGoogle Scholar
  5. Brooks, W. H., Nesby, M. G., Normansell, D. E., and Horwitz, D. A., 1972, Depressed cell mediated immunity in patients with primary intracranial tumors. Characterization of humoral immunosuppression factor, J. Exp. Med. 136: 1631.PubMedCrossRefGoogle Scholar
  6. Cooke, A., Hutchings, P. R., and Playfair, J. H. L., 1978, Suppressor T cells in experimental autoimmune haemolytic anaemia, Nature (London) 273: 154.CrossRefGoogle Scholar
  7. DeLeo, A. B., Shiku, H., Takahaski, T., John, M., and Old, L. J., 1977, Cell surface antigens and chemically induced sarcomas of the mouse. I. murine leukemia virus-related antigens and alloantigens on cultured fibroblasts and sarcoma cells. Description of a unique antigen in Balb/c metho A sarcoma, J. Exp. Med. 146: 720.PubMedCrossRefGoogle Scholar
  8. Ehrlich, R., and Witz, I. P., 1979, The elution of antibodies from viable murine tumor cells, J. Immunol. Methods 26: 345.PubMedCrossRefGoogle Scholar
  9. Forbes, A. P., Lake, J. F., and Bloch, K., 1976, Circulating antibody to renal collecting ducts in patients with hepatoma or renal cell carcinoma, Clin. Exp. Immunol. 26: 426.Google Scholar
  10. Fridman, H., Fradelizi, D., Guinezanes, A., Plater, C., and Leclerc, J. C., 1978, The role of the Fc receptor (FcR) of thymus-derived lymphocytes. II. Presence of FcR on suppressor cells and direct involvement in suppression, Eur. J. Immunol. 8: 549.Google Scholar
  11. Fujimoto, S., Green, M. I., and Sehon, A. H., 1976, Regulation of the immune response to tumor antigens. II. The nature of immunosuppressor cells in tumor-bearing hosts, J. Immunol. 116: 800.PubMedGoogle Scholar
  12. Furnie, G. J., Lambert, P. H., and Miescher, P. A., 1974, Release of DNA in circulating blood and induction of anti DNA antibodies after injection of bacterial lypopolysaccharide, J. Exp. Med. 140: 1189.CrossRefGoogle Scholar
  13. Gabbioni, G., Trencher, P., and Holborrow, E. J., 1975, Increase of contractile proteins in human cancer cells, Lancet 2: 796.CrossRefGoogle Scholar
  14. Galili, N., Naor, D., Asjo, B., and Klein, G., 1976, Induction of immune responsiveness in a genetically low-responsive tumor host combination by chemical modification of the immunogen, J. Immunol. 6: 473.Google Scholar
  15. Garrido, F., Schirrmacher, V., and Festenstein, M., 1976, H-2 like specificities of foreign haplotypes appearing on mouse sarcoma after vaccine virus injection, Nature (London) 259: 228.CrossRefGoogle Scholar
  16. Haba, S., Hamaoka, T., Takatsu, K., and Kitogawa, M., 1976, Selective suppression of T-cell activity in tumor-bearing mice and its improvement by lentinan, a potent antitumor polysaccharide, Int. J. Cancer 18: 93.PubMedCrossRefGoogle Scholar
  17. Holden, H. T., Haskill, J. S., Kirchner, H., and Herberman, R. B., 1976, Two distinct antitumor effector cells isolated from primary murine sarcomavirus-induced tumors, J. Immunol. 117: 440.PubMedGoogle Scholar
  18. Humphrey, L. J., Volenec, P. J., Volenec, F. J., and Cross, D., 1977, Autoantibodies to an altered IgG in human breast cancer, J. Surg. Oncol. 9: 29.PubMedCrossRefGoogle Scholar
  19. Ioachim, H. L., 1976, The stromal reaction of tumors. An expression of immune surveillance, J. Natl. Cancer Inst. 57: 465.PubMedGoogle Scholar
  20. Jacquemin, P. C., Saxinger, C., and Gallo, R. C., 1978, Surface antibodies of human myelogenous leukemia leukocytes reactive with specific type-C viral reverse transcriptases, Nature (London) 276: 230.CrossRefGoogle Scholar
  21. Kerbel, R. S., and Davies, A. J. S., 1974, The possible biological significance of Fc receptors in mammalian cells lymphocytes and tumor cells, Cell 3: 105.PubMedCrossRefGoogle Scholar
  22. Kerbel, R. S., Pross, H. F., and Elliot, E. V., 1975, Origin and partial characterization of Fc receptor-bearing cells found within experimental carcinomas and sarcomas, Int. J. Cancer 15: 918.PubMedCrossRefGoogle Scholar
  23. Kimura, A. K., Rubin, B., and Anderson, L. C., 1977, Evidence of K-cell killing by alloreactive Fe receptor-bearing cytotoxic T lymphocytes, Scand. J. Immunol. 6: 787.PubMedCrossRefGoogle Scholar
  24. Klein, G., Ehlin, B., and Witz, I. P., 1977, Serological detection of a polyoma-tumor-associated membrane antigen, Int. J. Cancer 23: 683.CrossRefGoogle Scholar
  25. Leclerc, J. C., Platen, C., and Fridman, W. H., 1977, The role of the Fc receptor (FcR) of thymus-derived lymphocytes. I. Presence of FcR on cytotoxic lymphocytes and absence of direct role in cytotoxicity, Eur. J. Immunol. 8: 543.CrossRefGoogle Scholar
  26. Martin, W. J., and Martin, S. E., 1975, Thymus reactive IgM autoantibodies in normal mouse sera, Nature (London) 254: 716.CrossRefGoogle Scholar
  27. McMaster, R., Buhler, K., Whitney, R., and Levy, J. G., 1977, Immunosuppression of T lymphocyte function by fractionated serum from tumor bearing mice, J. Immunol. 118: 218.PubMedGoogle Scholar
  28. Milgrom, F., Humphrey, L., Thnder, O., Yasuda, J., and Witebsky, E., 1968, Antibody mediated hemadsorption by tumor tissues, Int. Arch. Allergy Appl. Immunol. 33: 478.PubMedCrossRefGoogle Scholar
  29. Moav, N., and Witz, I. P., 1978, Characterization of immunoglobulins eluted from murine tumor cells. Binding patterns of cytotoxic anti-tumor IgG, J. Immunol. Methods 22: 51.PubMedCrossRefGoogle Scholar
  30. Müller, N., and Koenig, U. D., 1977, Cold lymphocytotoxic antibodies in sera of patients with cervical carcinoma, Blut 34: 479.PubMedCrossRefGoogle Scholar
  31. Nelson, D. S., 1977, Autoantibodies in cancer patients, Pathology 9: 155.PubMedCrossRefGoogle Scholar
  32. Nepom, J. T., Hellström, I., and Hellström, K. E., 1976, Purification and partial characterization of a tumor-specific blocking factor from sera of mice with growing chemically induced sarcomas, J. Immunol. 117: 1846.PubMedGoogle Scholar
  33. Profitt, M. R., Hirsh, M. S., Ellis, D. A., Gheridian, B., and Black, P. H., 1975, Immunological mechanisms in the pathogenesis of virus-induced murine leukemia. II. Target cell specificity of auto reactive thymocytes, J. Immunol. 117: 11.Google Scholar
  34. Quan, P. C., and Burtin, P., 1978, Demonstration of nonspecific suppressor cells in the peripheral lymphocytes of cancer patients, Cancer Res. 38: 288.PubMedGoogle Scholar
  35. Ran, M., and Witz, I. P., 1970, Tumor-associated immunoglobulins. The elution of IgG2 from mouse tumors, Int. J. Cancer 6: 361.PubMedCrossRefGoogle Scholar
  36. Ran, M., Klein, G., and Witz, I. P., 1976, Tumor-bound immunoglobulins. Evidence for the in vivo coating of tumor cells by potentially cytotoxic antitumor antibodies, Int. J. Cancer 4: 90.CrossRefGoogle Scholar
  37. Ran, M., Yaakubowicz, M., and Witz, I. P., 1978, Lymphocytotoxic autoantibodies eluted from in vivo propagating sarcoma cells: Brief communication, J. Natl. Cancer Inst. 60: 1509.PubMedGoogle Scholar
  38. Rand, R. J., Henkins, D. M., and Bulmer, R., 1977, T and B lymphocyte subpopulations in preinvasive and invasive carcinoma of the cervix, Clin. Exp. Immunol. 30: 421.PubMedGoogle Scholar
  39. Shiku, H., Takahasi, T., Resnick, L. A., Oettgen, H. R., and Old, L. T., 1977, Cell surface antigens of human malignant melanoma. III. Recognition of autoantibodies with unusual characteristics, J. Exp. Med. 145: 784.PubMedCrossRefGoogle Scholar
  40. Sjörgren, H. A., 1964a, Studies on specific transplantation resistance to polyoma-virusinduced tumors. I. Transplantation resistance induced by polyoma-virus injection, J. Natl. Cancer Inst. 32: 361.Google Scholar
  41. Sjörgren, H. A., 1964b, Studies on specific transplantation resistance to polyoma-virusinduced tumors. II. Mechanism of resistance induced by polyoma-virus injection, J. Natl. Cancer Inst. 32: 375.Google Scholar
  42. Steinberg, A. K., Gershwin, M. E., and Gerber, N. L., 1975, Role of suppressor cells in the pathogenesis of autoimmunity in New Zealand mice, in: Immune Depression and Cancer ( G. W. Siskind, C. L. Christian, and S. D. Litwin, eds.), p. 42, Grune and Stratton, New York.Google Scholar
  43. Stout, R. D., Murphy, D. B., McDevitt, H. O., and Herzenberg, L. A., 1977, The Fc receptor on thymus-derived lymphocytes. IV. Inhibition of binding of antigen-antibody complexes to Fc receptor-positive T cells by anti-la sera. J. Exp. Med. 145: 187.PubMedCrossRefGoogle Scholar
  44. Succi-Foca, N., Buda, J., McManus, J., Threpp, T., and Rumsta, K., 1973, Impaired responsiveness of lymphocytes and serum inhibitory factors in patients with cancer, Cancer Res. 33: 2373.Google Scholar
  45. Sugai, S., Palmer, D. W., Talai, W., and Witz, I. P., 1974, Protective and cellular immune responses to idiotypic determinants on cells from a spontaneous lymphoma of NZB/NZW Fl mice, J. Exp. Med. 140: 1547.PubMedCrossRefGoogle Scholar
  46. Talai, N., and Steinberg, A. K., 1974, The pathogenesis of autoimmunity in New Zealand black mice, Curr. Top. Microbial. Immunol. 64: 79.CrossRefGoogle Scholar
  47. Thunold, S., Abeyounis, C. J., Milgrom, F., and Witebsky, E., 1970, Anti-y-globulin factors in serum and tissue of cancer patients, Int. Arch. Allergy Appl. Immunol. 38: 260.PubMedCrossRefGoogle Scholar
  48. Toh, B. H., and Müller, H. K., 1975, Smooth muscle-associated antigen in experimental cutaneous squamous cell carcinoma, keratoacantoma and papilloma, Cancer Res. 33: 3741.Google Scholar
  49. T56nder, O., and Thunold, S., 1973, Receptors for immunoglobulin Fc in human malignant tissues, Scand. J. Immunol. 2: 207.PubMedCrossRefGoogle Scholar
  50. Tønder, O., Krishman, E. C., Jewell, W. R., Morse, P. A., Jr., and Humphrey, L. J., 1976, Tumor Fc receptors and tumor-associated immunoglobulins, Acta. PathoL Microbiol. Scand. Sect. C 84: 105.Google Scholar
  51. Waksman, B. H., and Tada, T., 1977, Specific and nonspecific suppressed T-cell factors derived from thymic lymphocytes, Cell. Immunol 30: 189.PubMedCrossRefGoogle Scholar
  52. Wasserman, J., Glass, U., and Blomgren, H., 1975, Autoantibodies in patients with carcinoma of the breast. Correlation with prognosis, Clin. Exp. Immunol. 19: 417.PubMedGoogle Scholar
  53. Whitney, R. B., Kelly, D. B., and Levy, J. C., 1978, Immunosuppression in mice bearing primary tumors, Eur. J. Cancer 14: 699.PubMedGoogle Scholar
  54. Witz, I. P., 1977, Tumor-bound immunoglobulins. In situ expression of tumor immunity, Adv. Cancer Res. 25: 95.PubMedCrossRefGoogle Scholar
  55. Witz, I. P., Lee, W., and Klein, G., 1976, Serologically detectable specific and cross reactive antigens on the membrane of a polyoma-virus-induced murine tumor, Int. J. Cancer 18: 243.PubMedCrossRefGoogle Scholar
  56. Wood, A. W., Gillespie, G. V., and Barth, R. F., 1975, Receptor sites for antigen-antibody complexes on cells derived from solid tumors. Detection by means of antibody sensitized sheep erythrocytes labeled with technetium 99m, J. Immunol. 114: 950.PubMedGoogle Scholar
  57. Yasuda-Yasaki, Y., and Yoshida, T. O., 1975, Isolation of a “speckled” nuclear antigen reactive with autoantibodies in patients with cancer and autoimmune diseases, Scand. J. Immunol. 21: 357.CrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 1980

Authors and Affiliations

  • Maya Ran
    • 1
  • Margalit Yaakubowicz
    • 1
  • Ora Amitai
    • 1
  • Isaac P. Witz
    • 1
  1. 1.Department of Microbiology, The George S. Wise Faculty of Life SciencesTel Aviv UniversityTel AvivIsrael

Personalised recommendations